February 11, 2019 - "The Next Billion-Dollar Acquisition in Pharma -- A Forward-Looking Patent Analysis on Bristol-Myers Squibb Acquiring Celgene" (LexisNexis) - 2:00 pm (ET)
February 12, 2019 - "Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements -- Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections" (Strafford) - 1:00 to 2:30 pm (EST)
February 14, 2019 - "Section 112 Issues in IPR Proceedings: Using Section 112 as a Sword or a Shield -- Addressing Section 112 Issues in IPR Petitions, Establishing Priority or Earlier Critical Date of Asserted Reference, and More" (Strafford) - 1:00 to 2:30 pm (EST)
February 20, 2019 - "New Developments in Patent-Eligibility with a Focus on the Abstract Idea Exception" (McDonnell Boehnen Hulbert & Berghoff LLP) - 10:00 am to 11:15 am (CT)
February 21, 2019 - "Infringement of IP Rights in Augmented and Virtual Reality -- Protecting and Monitoring Trademarks, Right of Publicity, Copyrights" (Strafford) - 1:00 to 2:30 pm (EST)
February 27, 2019 - "Conducting and Analyzing Prior Art Searches -- Strategies for Validity, Patentability, Infringement, FTO and State-of-the-Art Searches" (Strafford) - 1:00 to 2:30 pm (EST)
Comments